NCT06323265View on ClinicalTrials.gov

A Real-world Study of Adebrelimab Combined With Chemotherapy±Chest Radiotherapy in Patients With Extensive Stage Small Cell Lung Cancer

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 26, 2024

Primary Completion Date

April 1, 2025

Study Completion Date

April 1, 2026

Conditions
Extensive Stage Small Cell Lung Cancer
Interventions
DRUG

Adebrelimab + chemotherapy

Adebrelimab: 1200mg, d1, iv (30-60min), Q3W ,up to progressive disease or toxicity intolerable Chemotherapy: etoposide 100mg/m2，d1-3，iv；carboplatin AUC=5-6，d1，iv；or cisplatin 75mg/m2，d1，iv，Q3W，4 cycles；

RADIATION

±chest radiotherapy

Chest radiotherapy: 3Gy/15f-18f or 2Gy/20f-25f

Trial Locations (1)

Unknown

RECRUITING

Jun Wang, Shijiazhuang

All Listed Sponsors
lead

Hebei Medical University Fourth Hospital

OTHER